B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gilteritinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gilteritinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

k
47 shared targets
cyc
40 shared targets
pazopanib
38 shared targets
pf
33 shared targets
at
40 shared targets
milciclib
31 shared targets
pacritinib
23 shared targets
tozasertib
50 shared targets
tae
65 shared targets
cediranib
28 shared targets
Loading evidence profile...

This evidence profile for Gilteritinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.